Caricamento...
COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)
There are two key needs in COVID-19 management: (i) to reduce SARS-CoV-2 viral infection rate; and (ii) to reduce death rate of those infected - the subject of this commentary. The current WHO estimated global mortality rate is 3.4% (March 2020) and the global death toll has now past 200,000 (April...
Salvato in:
| Pubblicato in: | Med Drug Discov |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier B.V
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227543/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medidd.2020.100043 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|